Law.com Subscribers SAVE 30%

Call 855-808-4530 or email [email protected] to receive your discount on a new subscription.

Search

We found 6,352 results for "Marketing the Law Firm"...

Second Annual Best of Visual Identity Innovators
March 30, 2005
Once again this year Marketing The Law Firm is presenting its Best of Visual Identity Innovators. This competition was open only to law firms of all sizes. The graphic design firm or those responsible for the creative side of the project receive "honorable mention."
Media & Communications Corner: <b>In-House PR and Agency Support: A Great Partnership</b>
March 30, 2005
When partners gather to discuss the firm image and the success of the marketing department, they typically start with comments about how often the firm's name appears in the local paper and legal trade publications.
Is It Forgettable, Or Is It Memorable?
March 30, 2005
Memorability is what matters most in advertising. To be memorable, the advertising must be credible. Distinct. And most of all, relevant to the self-interest of the audience by which the advertiser wants to be remembered. <br>The question is: Why isn't most law firm advertising more memorable?
Has Anything Been Learned About Crisis Media?
March 30, 2005
One would think, after all this time has passed, that everyone in the world would know how to better handle a media crisis.
Letter From the Editor
March 30, 2005
I'm so thrilled to present our Second Annual Best of Visual Identity Innovators. We received quite a few entries and it was difficult to pick the best,…
Dilemma over Drug Safety
March 30, 2005
There is a newly urgent push from outside the pharmaceutical research and development community to get drug firms and the government to disclose the results of all tests conducted on new drugs and to immediately reveal information about problems that develop after those drugs go on the market. Consumers and health care providers say they're tired of finding out belatedly that negative information has come to light about the drugs they take or prescribe.
The TAP Pharmaceutical Acquittals
March 30, 2005
In 2001, the U.S. Attorney in Boston charged TAP Pharmaceutical Products Inc. (TAP) with conspiring to provide urologists with thousands of free samples of Lupron', for which the doctors billed Medicare and their patients. In order to survive and continue selling its blockbuster product for advanced prostate cancer, TAP made a reasoned decision to pay the government $885 million to resolve both civil and criminal charges. With this resolution, Boston's talented federal prosecutors continued their remarkable success in bringing major pharmaceuticals to their knees and reaching landmark settlements.
Lateral Partner Recruiting Effective Use Of Search Professionals
March 30, 2005
Cravath, Swaine &amp; Moore, one of New York's elite law firms, recently hired its first lateral partner in over 60 years. While an exception at Cravath, hiring lateral partners has become an indispensable strategy for law firms in achieving important business objectives and in thriving in hotly competitive markets.
Need Partners Who Can Effectively Manage Your Firm?
March 30, 2005
As I work with partners in law firms throughout the country, I continue to be surprised at how little, if any, formal training they have had in the business of law ' leadership, management, profitability, and business development. <br>Lawyers are largely extremely bright and talented people. Most, however, do not have MBAs, did not study business in college and do not devote sufficient non-billable time each year to ongoing leadership and management training courses.
Net News
March 30, 2005
Recent developments of note in the Internet industry. This month:<br>CA Judge Orders Online Reporters to Reveal Sources in Apple Computer Case<br>Hollywood Studios File New Round of Web Lawsuits <br>British Court Forces ISPs to Reveal Music Sharers <br>Movie Downloading Judged Legal in France <br>eBay Loses Patent Case; Injunction May Follow

MOST POPULAR STORIES

  • Private Equity Valuation: A Significant Decision
    Insiders (and others) in the private equity business are accustomed to seeing a good deal of discussion ' academic and trade ' on the question of the appropriate methods of valuing private equity positions and securities which are otherwise illiquid. An interesting recent decision in the Southern District has been brought to our attention. The case is <i>In Re Allied Capital Corp.</i>, CCH Fed. SEC L. Rep. 92411 (US DC, S.D.N.Y., Apr. 25, 2003). Judge Lynch's decision is well written, the Judge reviewing a motion to dismiss by a business development company, Allied Capital, against a strike suit claiming that Allied's method of valuing its portfolio failed adequately to account for i) conditions at the companies themselves and ii) market conditions. The complaint appears to be, as is often the case, slap dash, content to point out that Allied revalued some of its positions, marking them down for a variety of reasons, and the stock price went down - all this, in the view of plaintiff's counsel, amounting to violations of Rule 10b-5.
    Read More ›